BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 1862876)

  • 1. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the acceptability of inert and copper-containing intrauterine contraceptive devices].
    Manuilova IA; Dubnitskaia LV
    Akush Ginekol (Mosk); 1988 Nov; (11):47-50. PubMed ID: 3239684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interception by post-coital IUD insertion.
    Van Santen MR; Haspels AA
    Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical carcinogenesis and contraception.
    Misra JS; Engineer AD; Das K; Tandon P
    Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health risks of intrauterine contraception (author's transl)].
    Keith LG; Berger GS; Edelman DA
    Contracept Fertil Sex (Paris); 1983 Jun; 11(6):801-8. PubMed ID: 12338737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices Wang S.S Cu 380 as compared to ML Cu 375, Nova T, T Cu 300, 7 Cu 200, Lippes Loop and Ohta Ring: clinical / physiopathological parameters.
    Wang FN; Hsu MC; Cheng CM; Su TP; Yeh KA; Lai WH; Hsiung CH; Karow WG; Tsai HD
    Adv Contracept Deliv Syst; 1992; 8(3):267-76. PubMed ID: 12285733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tubal infertility in relation to the use of an intrauterine device.
    Daling JR; Weiss NS; Metch BJ; Chow WH; Soderstrom RM; Moore DE; Spadoni LR; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):937-41. PubMed ID: 3974683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the intrauterine device.
    Mishell DR
    Fam Plann Perspect; 1975; 7(3):103-11. PubMed ID: 1140345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the uterine progesterone system (Progestasert R).
    Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
    Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects and complications of intrauterine devices with special reference to pelvic infection].
    Marchino GL; Grio R; Garyphallides N; Zaccheo F; Carbone G
    Minerva Ginecol; 1986 Nov; 38(11):953-7. PubMed ID: 3808430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.